TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
21 hedge funds and large institutions have $1.66M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$10.2K | |
| 2 | +$2.82K | |
| 3 | +$18 | |
| 4 |
JPMorgan Chase & Co
New York
|
+$4 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| 1 | -$132K | |
| 2 | -$22K | |
| 3 | -$14K | |
| 4 |
VF
Virtu Financial
New York
|
-$8K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$6.59K |